AJO LP’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-267,863
| Closed | -$16.9M | – | 419 |
|
|
2020
Q3 | $16.9M | Sell |
267,863
-18,040
| -6% | -$1.25M | 0.18% | 155 |
|
|
2020
Q2 | $22M | Sell |
285,903
-21,053
| -7% | -$1.61M | 0.2% | 121 |
|
|
2020
Q1 | $22.9M | Sell |
306,956
-878,725
| -74% | -$60.7M | 0.21% | 134 |
|
|
2019
Q4 | $77M | Buy |
1,185,681
+932,045
| +367% | +$60.7M | 0.46% | 74 |
|
|
2019
Q3 | $16.1M | Buy |
253,636
+22,881
| +10% | +$1.5M | 0.09% | 177 |
|
|
2019
Q2 | $15.6M | Sell |
230,755
-5,740
| -2% | -$378K | 0.08% | 193 |
|
|
2019
Q1 | $15.4M | Sell |
236,495
-58,647
| -20% | -$3.9M | 0.08% | 205 |
|
|
2018
Q4 | $18.5M | Sell |
295,142
-9,954
| -3% | -$696K | 0.1% | 175 |
|
|
2018
Q3 | $23.6M | Sell |
305,096
-309,786
| -50% | -$23.4M | 0.11% | 174 |
|
|
2018
Q2 | $43.6M | Buy |
614,882
+131,124
| +27% | +$9.26M | 0.2% | 134 |
|
|
2018
Q1 | $36.5M | Sell |
483,758
-798,841
| -62% | -$63.5M | 0.17% | 138 |
|
|
2017
Q4 | $91.9M | Sell |
1,282,599
-200,902
| -14% | -$15.3M | 0.4% | 84 |
|
|
2017
Q3 | $120M | Sell |
1,483,501
-923,894
| -38% | -$70.6M | 0.52% | 63 |
|
|
2017
Q2 | $170M | Sell |
2,407,395
-1,706,756
| -41% | -$114M | 0.73% | 42 |
|
|
2017
Q1 | $279M | Buy |
4,114,151
+269,452
| +7% | +$18.9M | 1.16% | 23 |
|
|
2016
Q4 | $275M | Buy |
3,844,699
+354,997
| +10% | +$26.4M | 1.13% | 21 |
|
|
2016
Q3 | $276M | Buy |
3,489,702
+343,284
| +11% | +$27.9M | 1.18% | 19 |
|
|
2016
Q2 | $262M | Buy |
3,146,418
+143,368
| +5% | +$12.7M | 1.17% | 20 |
|
|
2016
Q1 | $276M | Buy |
3,003,050
+294,465
| +11% | +$26.6M | 1.19% | 15 |
|
|
2015
Q4 | $274M | Buy |
2,708,585
+52,973
| +2% | +$5.51M | 1.19% | 18 |
|
|
2015
Q3 | $261M | Buy |
2,655,612
+166,712
| +7% | +$18.5M | 1.19% | 16 |
|
|
2015
Q2 | $291M | Buy |
2,488,900
+1,208,960
| +94% | +$132M | 1.24% | 11 |
|
|
2015
Q1 | $126M | Buy |
1,279,940
+34,620
| +3% | +$3.52M | 0.53% | 79 |
|
|
2014
Q4 | $117M | Buy |
1,245,320
+24,820
| +2% | +$2.57M | 0.5% | 79 |
|
|
2014
Q3 | $130M | Buy |
1,220,500
+169,080
| +16% | +$16.6M | 0.58% | 75 |
|
|
2014
Q2 | $87.2M | Buy |
1,051,420
+50,380
| +5% | +$3.92M | 0.37% | 94 |
|
|
2014
Q1 | $70.9M | Buy |
1,001,040
+493,740
| +97% | +$38.7M | 0.31% | 93 |
|
|
2013
Q4 | $38.1M | Buy |
507,300
+414,300
| +445% | +$28.8M | 0.17% | 117 |
|
|
2013
Q3 | $5.85M | Sell |
93,000
-416,100
| -82% | -$24.9M | 0.03% | 266 |
|
|
2013
Q2 | $26.1M | Buy |
+509,100
| New | +$26.5M | 0.12% | 127 |
|
Other funds holding GILD
AJO LP's GILD Position: Q4 2020 in Review
AJO LP sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 267,863 shares — an estimated $16.9M sold.
AJO LP first reported a position in GILD in Q2 2013 and held it in 30 quarters. The position peaked at $291M in Q2 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- AJO LP reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- AJO LP sold 267,863 Gilead Sciences shares in Q4 2020, an estimated $16.9M.
- AJO LP first reported a position in Gilead Sciences in Q2 2013 and held it in 30 quarters.
- AJO LP's Gilead Sciences position peaked at $291M in Q2 2015.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.